Project description:In vivo selection of ceftazidime-avibactam resistance in KPC-3 producing Klebsiella pneumoniae
| PRJEB44536 | ENA
Project description:Ceftazidime-avibactam Resistance in Klebsiella pneumoniae
| PRJNA1236832 | ENA
Project description:Ceftazidime-Avibactam Resistance Development following Ceftazidime-Avibactam-based therapy in critically-ill patients with infections caused by KPC-producing Klebsiella pneumoniae
| PRJNA839621 | ENA
Project description:Outbreak by KPC-62-producing Klebsiella pneumoniae isolates resistant to cefiderocol and ceftazidime-avibactam in a University Hospital in Madrid, Spain
Project description:Emergence of Ceftazidime-Avibactam resistant KPC-producing K. pneumoniae (KPC-Kp) during ceftazidime-avibactam-based antimicrobial treatment.
| PRJEB21871 | ENA
Project description:In vivo emergence of cross-resistance to ceftazidime/avibactam and cefiderocol through selection of KPC variants in Klebsiella pneumoniae clinical isolates
Project description:Using in vitro directed evolution, we show that mismatch repair-deficient Pseudomonas aeruginosa can engage novel resistance mechanisms to ceftazidime-avibactam.
Project description:The emergence and spread of polymyxin resistance, especially among Klebsiella pneumoniae isolates threaten the effective management of infections. This study profiled for polymyxin resistance mechanisms and investigated the activity of polymyxins plus vancomycin against carbapenem- and polymyxin-resistant K. pneumoniae.